In this compelling OIS podcast episode, host Dr. Rob Rothman engages in an insightful conversation with Dr. Malvina Eydelman, the Director of the FDA's Office of Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices. Delve into Malvina's

Empathy in Action

17 days ago 43m 51s

In the latest episode of the OIS podcast, host Dr. Rob Rothman delves into the transformative power of empathy with multi-Emmy award-winning actress and writer, Ellen Gould. Together, they explore the intersection of healthcare and storytelling

From Ophthalmology Clinics to Business Leadership

Mar 29th, 2024 51m 23s

In this episode, Dr. Jai Parekh shares his journey from ophthalmology to business leadership in healthcare. Raised in New Jersey, he initially pursued cardiology before discovering his passion for ophthalmology. Specializing in cornea and refra

Exploring the Future of Eye Care

Mar 15th, 2024 38m 31s

Don't miss the latest episode of the OIS Retina Podcast, where we sit down with optometrist and ophthalmology researcher Brian Levy for an illuminating discussion on the future of eye care. In this episode, Brian takes us on a journey through h

5 Mistakes to Avoid in Biotech Investor Pitch Decks

Mar 1st, 2024 18m 32s

Tune in to the latest episode of the Eye On Innovation podcast where Carey Powers dives into the dynamic world of biotech investor pitch decks with special guest Dr. Rob Rothman, Founding Partner of InFocus Capital Partners. Discover the top fi

Unlocking the Future of Presbyopia Treatment

Feb 16th, 2024 19m 32s

Join us this week on the OIS podcast as host Carey Powers sits down with Dr. Paul Karpecki to explore the latest advancements in presbyopia treatment strategies. Here's what you can expect from this insightful conversation:Insider Insights: Dr.

Revolutionizing Ophthalmic Care

Feb 2nd, 2024 37m 41s

In the latest episode of the OIS Podcast, host Dr. Robert Rothman engages in a captivating dialogue with Dr. Prasad Sunkara, CEO of Eyegenex.Key points discussed in the episode:Prasad's multifaceted background spanning agricultural sciences to

Insights from Startup Leaders on Commercial Strategy and Funding

Jan 19th, 2024 23m 39s

This panel discussion on startup commercial strategy explores key elements and insights from industry leaders, Paul Bresge, Aziz Mottiwala, Todd Pinkney, Cari Stone and Adam Szaronos, offering a comprehensive view of the journey from regulator

Maximizing the Value of Your Board of Directors

Jan 5th, 2024 22m 4s

OIS Podcast host Carey Powers speaks with Dr. Adrienne Graves and Dr. Barbara Wirostko on 'Maximizing the Value of Your Board of Director' live from OIS XIII.Dr. Graves and Dr. Wirostko share valuable insights on:* Building effective boards* Si

Quick Takes From Ophthalmology Start-Ups

Dec 22nd, 2023 28m 30s

Revolutionizing Retina Care Beyond Injections

Dec 15th, 2023 22m 10s

In this episode of the OIS Podcast, host Dr. Firas Rahhal, along with expert panelists, Dr. Robert Bhisitkul, Dr. Alan Franklin and Dr. Paul Karpecki at OIS XIII, takes listeners on a deep dive into the transformative landscape of oral therapie

Revolutionizing Glaucoma Treatment and Innovation Insights

Dec 1st, 2023 32m 51s

ViaLase, a clinical stage medical technology company located in Aliso Viejo, CA is focused on disrupting the conventional glaucoma treatment paradigm with the introduction of a truly noninvasive image-guided femtosecond laser treatment that enh

Ophthea's Transformative Shift, Clinical Successes, and Visionary Innovation

Nov 17th, 2023 42m 43s

Opthea, an Australian based biopharmaceutical company is dedicated to transforming retinal disease treatments and elevating patients' vision and quality of life. Join Firas Rahal, MD, in a captivating episode as he engages with Opthea's Founder

Building an Enterprise Under the Radar

Nov 3rd, 2023 33m 4s

Harrow isn’t a household name (yet), but eye care professionals have trusted its products for over a decade.The Nashville-based company produces Dexycu, an intraocular steroid; Iopidine for intraocular pressure control; and most recently, five

Approachable Regenerative Medicine

Oct 20th, 2023 36m 13s

Endogena Therapeutics has developed a novel approach to regenerative medicine that’s not only scientifically compelling, but practical.Endogena’s technology unlocks the body’s own stem cells for controlled tissue repair by small molecules. Its

The Bausch + Lomb Buzz, with Andrew Stewart and Yehia Hashad, MD

Oct 6th, 2023 28m 8s

“You can see and feel a buzz within the company right now,” said Andrew Stewart, President, Global Pharmaceuticals and International Consumer, at Bausch + Lomb.Bausch + Lomb’s current momentum stems not only from new leadership, but also from r

C-Suite Quick Takes: OIS Goes Behind the Scenes with Four Emerging Biotech Companies

Sep 22nd, 2023 20m 34s

OIS Podcast host Carey Powers caught up with four ophthalmology execs and one principal investigator to talk about some of the most exciting developments in retina R&D.Her guests include:Houman David Hemmati, MD, PhD, Cofounder and Chief Medica

CEO Quick Takes

Sep 8th, 2023 18m 4s

OIS Podcast host Carey Powers speaks with four CEOs from leading retina-focus companies to talk about all things innovation. Her guests include:• Kerrie Brady, BPharm, President and CEO of OcuTerra• Rich Small, CEO of NeuroTech Pharmaceutical

The Latest on At-Home OCT

Aug 18th, 2023 14m 12s

At-home OCT enables daily monitoring of patients with neovasular age-related macular degeneration (AMD) and other patients that need a lot of follow-ups.With host Carey Powers, Dr. Anat Loewenstein dives into at-home OCT innovation, application

Accessing Charitable Resources

Aug 11th, 2023 37m 19s

Keith Valentine is the first and only visually impaired head of a national sight loss organization in the UK.As the President and CEO of Vision Foundation, London’s leading sight loss charity, Valentine guides an organization that provides serv

What’s New in Ocular Surface Disease?

Aug 4th, 2023 22m 11s

Two recent drug approvals changed the game for ocular surface disease: Xdemvy (lotilaner ophthalmic solution) 0.25 percent (Tarsus Pharmaceuticals) for Demodex blepharitis, and Miebo (perfluorohexyloctane ophthalmic solution) from Bausch + Lomb

Accessing Capital and Navigating M&As

Jul 28th, 2023 22m 50s

Yari Mitchell spent nearly 13 years with AcuFocus, an ophthalmic device company, before overseeing its acquisition by Bausch + Lomb. As head of Y Factor Consulting, she now helps innovators move their product from the lab to a funded company.Gr

When Is the Right Time to Form a Spin-Out? With Wesley Jackson, PhD, Valitor

Jul 21st, 2023 50m 6s

Wesley Jackson, PhD, spent years conducting post-doctoral research and writing grants, all the while setting the wheels in motion to launch Valitor.Valitor is developing VLTR-557 a long-lasting anti-VEGF. The technology platform, a multivalent

Commercializing Demedex Blepharitis

Jul 14th, 2023 24m 27s

Aziz Mottiwala, Chief Commercial Officer of Tarsus Pharmaceuticals, says the company looks for honest unmet needs when deciding what targets to explore. It also looks for opportunities to be the first or the best.The company may meet both objec

From Lab Learning to Machine Learning, with Daniela Ferrara, Genentech

Jul 7th, 2023 46m 2s

Daniela Ferrara, Principal Medical Director at Genentech, calls her extensive medical training in Brazil her “north star.” Yet, she was frustrated by the limitations of clinical practice. “Having patients go blind under my watch, I realized I w